Dan Robbins

Dan Robbins

Company: Nurix Therapeutics

Job title: Associate Director, Medicinal Chemistry


Live Panel Q&A – Ask the Speakers Your Burning Questions 10:40 am

Read more

day: Day Two

Application of DNA-Encoded Libraries to Discover Small Molecules for E3 Ligase Modulation 9:50 am

Outlining the use of Nurix’s DELigase platform to discover binders to E3 ligases Identification and optimization of ligands with unique mechanism of action Prospects for use of E3 ligase binders for TPD/therapeutic applicationRead more

day: Day Two

Roundtable Session: Tissue & Cell Selectivity – Highlighting the Potential for Selective E3 Targeting 2:30 pm

As expression and profiling data begin to shed light on the distribution of E3’s across cell and tissue types, it is becoming evident that such data may provide promising insights to aid the development of tissue E3 specific targeting, within a therapeutic context. What is the difficulty of selectively targeting E3’s in tumor cells and…Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.